APA (7th ed.) Citation

Dreger, P., Schnaiter, A., Zenz, T., Böttcher, S., Rossi, M., Paschka, P., . . . Stilgenbauer, S. (2013). TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: Six-year follow-up of the GCLLSG CLL3X trial. Blood, 121(16), . https://doi.org/10.1182/blood-2012-11-469627

Chicago Style (17th ed.) Citation

Dreger, Peter, et al. "TP53, SF3B1, and NOTCH1 Mutations and Outcome of Allotransplantation for Chronic Lymphocytic Leukemia: Six-year Follow-up of the GCLLSG CLL3X Trial." Blood 121, no. 16 (2013). https://doi.org/10.1182/blood-2012-11-469627.

MLA (9th ed.) Citation

Dreger, Peter, et al. "TP53, SF3B1, and NOTCH1 Mutations and Outcome of Allotransplantation for Chronic Lymphocytic Leukemia: Six-year Follow-up of the GCLLSG CLL3X Trial." Blood, vol. 121, no. 16, 2013, https://doi.org/10.1182/blood-2012-11-469627.